Prudential Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Buy |
|
|||||
|
2025
Q1 | $9.1M | Sell |
|
|||||
|
2024
Q4 | $9.43M | Buy |
|
|||||
|
2024
Q3 | $4.37M | Buy |
|
|||||
|
2024
Q2 | $1.55M | Sell |
|
|||||
|
2024
Q1 | $3.9M | Buy |
|
|||||
|
2023
Q4 | $4.12M | Sell |
|
|||||
|
2023
Q3 | $6.92M | Buy |
|
|||||
|
2023
Q2 | $5.61M | Sell |
|
|||||
|
2023
Q1 | $27.5M | Buy |
|
|||||
|
2022
Q4 | $14.6M | Buy |
|
|||||
|
2022
Q3 | $7.96M | Sell |
|
|||||
|
2022
Q2 | $10.4M | Buy |
|
|||||
|
2022
Q1 | $6.75M | Buy |
|
|||||
|
2021
Q4 | $5.71M | Buy |
|
|||||
|
2021
Q3 | $804K | Sell |
|
|||||
|
2021
Q2 | $887K | Sell |
|
|||||
|
2021
Q1 | $820K | Sell |
|
|||||
|
2020
Q4 | $4.65M | Sell |
|
|||||
|
2020
Q3 | $4.29M | Sell |
|
|||||
|
2020
Q2 | $7.71M | Sell |
|
|||||
|
2020
Q1 | $6.95M | Sell |
|
|||||
|
2019
Q4 | $9.42M | Buy |
|
|||||
|
2019
Q3 | $7.18M | Buy |
|
|||||
|
2019
Q2 | $8.9M | Buy |
|
|||||
|
2019
Q1 | $9.18M | Sell |
|
|||||
|
2018
Q4 | $9.44M | Sell |
|
|||||
|
2018
Q3 | $12.6M | Sell |
|
|||||
|
2018
Q2 | $15M | Sell |
|
|||||
|
2018
Q1 | $13.8M | Buy |
|
|||||
|
2017
Q4 | $14.3M | Hold |
|
|||||
|
2017
Q3 | $14.8M | Buy |
|
|||||
|
2017
Q2 | $13.2M | Buy |
|
|||||
|
2017
Q1 | $12.4M | Buy |
|
|||||
|
2016
Q4 | $11.1M | Buy |
|
|||||
|
2016
Q3 | $12.1M | Sell |
|
|||||
|
2016
Q2 | $11.1M | Buy |
|
|||||
|
2016
Q1 | $11.7M | Buy |
|
|||||
|
2015
Q4 | $11.3M | Buy |
|
|||||
|
2015
Q3 | $6.78M | Buy |
|
|||||
|
2015
Q2 | $1.13M | Buy |
|
|||||
|
2015
Q1 | $1.01M | Sell |
|
|||||
|
2014
Q4 | $742K | Sell |
|
|||||
|
2014
Q3 | $805K | Sell |
|
|||||
|
2014
Q2 | $1.16M | Buy |
|
|||||
|
2014
Q1 | $774K | Sell |
|
|||||
|
2013
Q4 | $805K | Sell |
|
|||||
|
2013
Q3 | $950K | Sell |
|
|||||
|
2013
Q2 | $742K | Buy |
|